Prophylactic antibiotic treatment with TMP-SMX decreased the incidence of interstitial pneumonia in patients with B-cell lymphoma on chemotherapy

BACKGROUND: Several studies have reported the incidence of interstitial pneumonia (IP) among patients with non-Hodgkin lymphoma (NHL) that are undergoing combination chemotherapy plus rituximab; however, the effective prophylactic treatment for IP remains unclear. This study aims to explore the prop...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Cong, Lu, Fangxiao, Lei, Tao, Yu, Haifeng, Chen, Xi, Peng, Shuailing, Han, Shuiyun, Yang, Haiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414680/
https://www.ncbi.nlm.nih.gov/pubmed/32770971
http://dx.doi.org/10.1186/s12885-020-07254-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414680/
https://www.ncbi.nlm.nih.gov/pubmed/32770971
http://dx.doi.org/10.1186/s12885-020-07254-w

Ejemplares similares